Pro Pharmaceuticals Group

Accelerating Access. Transforming Lives Worldwide. Founded in 2015, Pro Pharmaceuticals Group (ProPG) is a 100% Australian-owned company dedicated to solving critical medicine access challenges. We are the trusted partner for hospitals, CROs, and public health institutions needing compliant, ethical, and rapid solutions when traditional supply chains fail. We specialise in: Unlicensed Medicines – supply under Australia’s SAS & Section 19A pathways. Drug Shortage Response – securing essential hospital medicines during shortages. Comparator (RLD) Sourcing – global access for clinical trials and bioequivalence studies. Global Access Partnerships – strengthening healthcare systems worldwide. Why partners choose ProPG: 100% Australian-owned — unlike competitors backed by offshore private equity. Proven expertise in GMP/GDP-aligned logistics and regulatory navigation. Innovative digital tools (CheckMed, ProPortal, ProTrack) streamlining access. Patient-centric focus: access is not a privilege — it’s our responsibility. Headquartered in Melbourne, with a growing footprint across Europe and New Zealand, ProPG delivers medicines when and where patients need them most.